PT  - JOURNAL ARTICLE
AU  - Sotolongo-Costa, Oscar
AU  - Weberszpil, José
AU  - Sotolongo-Grau, Oscar
TI  - A Fractal Viewpoint to COVID-19 Infection
AID  - 10.1101/2020.06.03.20120576
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.03.20120576
4099  - http://medrxiv.org/content/early/2020/06/17/2020.06.03.20120576.short
4100  - http://medrxiv.org/content/early/2020/06/17/2020.06.03.20120576.full
AB  - One of the central tools to control the COVID-19 pandemics is the knowledge of its spreading dynamics. Here we develop a fractal model capable of describe this dynamics, in term of daily new cases, and provide quantitative criteria for some predictions. We propose a fractal dynamical model using conformed derivative and fractal time scale. A Burr-XII shaped solution of the fractal-like equation is obtained. The model is tested using data from several countries, showing that a single function is able to describe very different shapes of the outbreak. The diverse behavior of the outbreak on those countries is presented and discussed. Moreover, a criterion to determine the existence of the pandemic peak and a expression to find the time to reach herd immunity are also obtained.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo support funds.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:It's not the case.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data from: https://coronavirus.jhu.edu/data/new-cases. https://www.worldometers.info/.to.https://www.medrxiv.org/content/early/2020/05/04/2020.04.24.20078154.full.pdf.https://coronavirus.jhu.edu/data/new-cases.https://www.worldometers.info/.to.